Affiliation:
1. Yaroslavl State Pedagogical University named after K.D. Ushinsky;
Yaroslavl State Medical University
2. Yaroslavl State Pedagogical University named after K.D. Ushinsky
3. I.M. Sechenov First Moscow State Medical University (Sechenov University)
Abstract
Background. Determining changes in the content of monoamine neurotransmitters and their metabolites in brain structures is a necessary part of studying the pharmacodynamics of antiparkinsonian drugs. A method for the joint determination of norepinephrine, adrenaline, dopamine, serotonin, 5-hydroxyindole-3-acetic acid, 3,4-dihydroxyphenylacetic acid, homovanillic acid, vanillylmandelic acid in rat brain tissue has not previously been developed.The aim of the study. To develop and to validate a method for the quantitative determination of norepinephrine, adrenaline, dopamine, serotonin, 5-hydroxyindole3-acetic acid, 3,4-dihydroxyphenylacetic acid, homovanillic acid, vanillylmandelic acid in rat brain tissue using high-performance liquid chromatography in combination with tandem mass spectrometry (HPLC-MS/MS).Materials and methods. A method for determining monoamine mediators and their metabolites was developed using the HPLC-MS/MS method. Brain tissue homogenates were prepared using a mechanical hand-operated homogenizer. The effect of various antioxidants on the stability of norepinephrine, adrenaline, dopamine and 3,4-dihydroxyphenylacetic acid in the test samples was studied.Results. Chromatographic separation of sample components was carried out using two Synergi Max RP (20 × 2.0 mm, 2.5 µm) and Synergi Fusion RP 80Å (250 × 4.6 mm, 4 µm) chromatographic columns. Elution was carried out in a gradient mode using a mobile phase based on methanol and a 0.1% solution of formic acid in water. To prepare homogenate batches, the samples were diluted with a solution of internal standards in methanol. A 5% aqueous solution of ascorbic acid was chosen as an antioxidant stabilizer.Conclusion. The developed methodology has been fully validated and meets the requirements of Russian and international guidelines. The chosen stabilization method allows samples of brain homogenates to be stored for 30 days after collection.
Reference25 articles.
1. Guidelines for conducting preclinical studies of drugs. Part one. Moscow: Grif i K; 2012. (In Russ.).
2. Lu J, Sun F, Ma H, Qing H, Deng Y. Quantitative detection of dopamine, serotonin and their metabolites in rat model of Parkinson’s disease using HPLC-MS/MS. 2015 IEEE International Conference on Mechatronics and Automation. 2015: 1460-1465. doi: 10.1109/ICMA.2015.7237700
3. Yaichkov II, Dzhurko YA, Shitov LN. The main error in the analytical part of bioequivalence studies and pharmacokinetics. Medical Ethics. 2018; 6(1): 33-38. (In Russ.).
4. Khokhlov AL, Ryska M, Kukes VG, Pisachkova M, Pechena M, Yavorsky AN, et al. Modern approaches to conducting bioanalytical studies in the creation of drugs. Moscow: Russian Academy of Sciences; 2018. (In Russ.).
5. Grouzmann E, Centeno C, Eugster PJ. Quantification of vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid in urine using a dilute-and-shoot and ultra-high pressure liquid chromatography tandem mass spectrometry method. Clin Chem Lab Med. 2018; 56(9): 1533-1541. doi: 10.1515/cclm-2017-1120